Setidegrasib is an investigational new drug that is being evaluated by Astellas Pharma for the treatment of solid tumors. It is an PROTACs degrader of the KRAS protein harboring a G12D mutation.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.